{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "increases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uniprot:Q64757",
      "entity_text" : "PVI",
      "entity_type" : "protein"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "uniprot:Q6EVK6",
      "entity_text" : "ChR2",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "Using the nonparametric gain analysis (as described above for Arch data), we found that, for low-contrast stimulation, ChR2 mediated PVI activation produced a significant reduction in baseline (R min median : 0.97; signed-rank test, P < 0.001) and maximum activity during DRC stimulation (R max median : 0.967; signed-rank test, P = 0.013, XREF_FIG).",
  "reading_complete" : "2020-08-08T15:47:54Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-08T15:44:07Z",
  "trigger" : "mediated",
  "evidence" : [ "ChR2-mediated PVI" ],
  "pmc_id" : "7191518",
  "score" : 0
}